๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bone marrow involvement in mantle cell lymphoma

โœ Scribed by Kikkeri Naresh; Sarah Hartley; Donald Macdonald


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
182 KB
Volume
85
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Non-Hodgkin's lymphomas. I. Bone marrow
โœ Stephen E. Jones; Saul A. Rosenberg; Henry S. Kaplan ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 484 KB ๐Ÿ‘ 2 views

T w o hundred and eighteen untreated patients with non-Hodgkin's lymphomas, classified according to the scheme of Rappaport et al., were investigated for bone marrow involvement. No pattern of pretreatment laboratory abnormalities predicted which patients would have a positive bone marrow for lympho

Splenic involvement by blastic mantle ce
โœ Mollejo, M.; Lloret, E.; Solares, J.; Bergua, J.M.; Mateo, M.; Piris, M.A. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB ๐Ÿ‘ 1 views

The most cases of splenic marginal zone lymphoma (SMZL) seem to respond favorably to splenectomy. The diagnosis of this lymphoma is mainly based on the recognition of a micronodular pattern of splenic involvement with marginal zone differentiation. However, it is possible to find so-called "marginal

Bone involvement in Hairy-cell leukemia
โœ D. Jeffrey Demanes; Nancy Lane; Jay H. Beckstead ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 493 KB ๐Ÿ‘ 1 views

Destructive bone involvement is a rarely recognized complication of hairy-cell leukemia (leukemic reticuloendotheliosis). We report a case in which localized hip pain and lytic bone lesions were the presenting manifestations. A second case of bone involvement in a patient with previously diagnosed h

Patterns of bone marrow involvement with
โœ Gerald H. Clamon; William R. Edwards; James E. Hamous; Richard K. Scupham ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 316 KB ๐Ÿ‘ 2 views

The extent of tumor involvement, necrosis, reticulin, and megakaryocytosis were assessed in 25 patients with small cell lung cancer in their bone marrow at diagnosis. The pattern of marrow involvement was compared with clinical outcome and tolerance of therapy. Any marrow involvement, no matter how